ロード中...
Type 1 interferons as a potential treatment against COVID-19
Type 1 interferons have a broad antiviral activity in vitro and are currently evaluated in a clinical trial to treat MERS-CoV. In this review, we discuss preliminary data concerning the potential activity of type 1 interferons on SARS-CoV-2, and the relevance of evaluating these molecules in clinica...
保存先:
| 出版年: | Antiviral Res |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier B.V.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7138382/ https://ncbi.nlm.nih.gov/pubmed/32275914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2020.104791 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|